INNATE PHARMA SA-SPONS ADR (IPHA) Stock Balance Sheet
NASDAQ:IPHA • US45781K2042
Current stock price
1.3 USD
+0.05 (+4%)
Last:
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 53.70M | 66.40M | 70.61M | 84.22M | 103.76M | |||
| Marketable Securities | 6.32M | 14.37M | 21.85M | 17.26M | 16.08M | |||
| Receivables | 1.21M | 1.64M | 46.49M | 31.02M | 13.47M | |||
| Other Current Assets | 3.75M | 3.33M | 9.07M | 7.32M | 4.95M | |||
| Total Current Assets | 64.98M | 85.74M | 148.01M | 139.83M | 138.26M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.96M | 5.13M | 6.32M | 8.54M | 10.17M | |||
| Investments And Advances | 10.39M | 10.28M | 9.80M | 35.12M | 39.88M | |||
| Intangibles | N/A | 0.00 | 416.00K | 1.56M | 44.19M | |||
| Other Non-Current Assets | 1.00K | N/A | 9.01M | 8.57M | 5.03M | |||
| Total Non-Current Assets | 27.96M | 25.32M | 36.18M | 68.03M | 129.24M | |||
| TOTAL ASSETS | 92.94M | 111.06M | 184.19M | 207.86M | 267.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 7.42M | |||
| Current Portion Of LT Debt. | 8.93M | 8.71M | 8.94M | 2.10M | 30.75M | |||
| Accrued Expenses | 6.59M | 6.96M | 7.02M | 5.98M | 7.46M | |||
| Accounts Payable | 16.59M | 23.93M | 25.58M | 13.67M | 14.73M | |||
| Other Current Liabilities | 9.35M | 9.39M | 15.12M | 19.59M | 19.53M | |||
| Total Current Liabilities | 29.43M | 32.98M | 39.64M | 41.34M | 79.89M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 18.09M | 22.29M | 75.99M | 93.14M | 46.50M | |||
| Deferred Taxes/Income | N/A | N/A | 9.01M | 8.57M | 5.03M | |||
| Other Non-Current Liabilities | 40.27M | 46.96M | 7.66M | 10.67M | 28.64M | |||
| Total Non-Current Liabilities | 58.37M | 69.24M | 92.66M | 112.37M | 80.17M | |||
| TOTAL LIABILITIES | 87.79M | 102.22M | 132.29M | 153.71M | 160.06M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -406.51M | -386.34M | -336.40M | -329.50M | -271.76M | |||
| Additional Paid In Capital | 407.05M | 390.98M | 384.25M | 379.64M | 375.22M | |||
| Common Shares | 4.61M | 4.19M | 4.04M | 4.01M | 3.98M | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | -1.00K | |||
| Shares Outstanding | 99.35M | 90.36M | 87.15M | 85.73M | 85.73M | |||
| Tangible Book Value per Share | 0.06 | 0.11 | 0.64 | 0.66 | 0.80 | |||
| Total Shareholders' Equity | 5.14M | 8.83M | 51.90M | 54.15M | 107.44M | |||
| TOTAL LIABILITIES AND EQUITY | 92.94M | 111.06M | 184.19M | 207.86M | 267.50M | |||
| Statistics | ||||||||
| Debt/Equity | 3.52 | 2.52 | 1.46 | 1.72 | 0.50 | |||
| Current Ratio | 2.21 | 2.60 | 3.73 | 3.38 | 1.73 | |||
| Return On Assets (ROA) | -49.55% | -44.54% | -4.11% | -27.95% | -19.74% | |||
| Return On Equity (ROE) | -895.24% | -560.01% | -14.59% | -107.30% | -49.15% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | N/A | N/A | |||
All data in EUR , ROIC based on taxRate of 0.21